In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.
- DOI
- 10.1084/jem.20120950
- Published
- 2013 May 6
- Container
- The Journal of experimental medicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 0/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- serious concernRetraction Watch expression of concern: 1 expression of concern notice matched this DOI.
- cautionRetraction Watch correction: 1 correction notice matched this DOI.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1084/jem.20120950,
title = {In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.},
author = {Pichiorri F and Palmieri D and De Luca L and Consiglio J and You J and Rocci A and Talabere T and Piovan C and Lagana A and Cascione L and Guan J and Gasparini P and Balatti V and Nuovo G and Coppola V and Hofmeister CC and Marcucci G and Byrd JC and Volinia S and Shapiro CL and Freitas MA and Croce CM},
year = {2013},
journal = {The Journal of experimental medicine},
doi = {10.1084/jem.20120950},
url = {https://doi.org/10.1084/jem.20120950}
}RIS
TY - JOUR TI - In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation. AU - Pichiorri F AU - Palmieri D AU - De Luca L AU - Consiglio J AU - You J AU - Rocci A AU - Talabere T AU - Piovan C AU - Lagana A AU - Cascione L AU - Guan J AU - Gasparini P AU - Balatti V AU - Nuovo G AU - Coppola V AU - Hofmeister CC AU - Marcucci G AU - Byrd JC AU - Volinia S AU - Shapiro CL AU - Freitas MA AU - Croce CM PY - 2013 JO - The Journal of experimental medicine DO - 10.1084/jem.20120950 UR - https://doi.org/10.1084/jem.20120950 ER -
APA
F, P., D, P., L, D. L., J, C., J, Y., A, R., T, T., C, P., A, L., L, C., J, G., P, G., V, B., G, N., V, C., CC, H., G, M., JC, B., S, V., CL, S., MA, F., & CM, C. (2013). In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.. The Journal of experimental medicine. https://doi.org/10.1084/jem.20120950
Source records
- pubmed · retrieved 2026-09-25T00:33:26.743Z